<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BackgroundMultifactorial intervention is unable to improve <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e>/cardiovascular outcome in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Intensive insulin therapy improves pancreatic β-cell dysfunction in patients with early stage <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated the effect of intensive insulin therapy on <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> in these patients.MethodsOne hundred and sixteen patients with newly diagnosed type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and 59 healthy subjects received flow-mediated <z:mpath ids='MPATH_66'>dilatation</z:mpath> (FMD) and <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor (vWF) measurement </plain></SENT>
<SENT sid="3" pm="."><plain>Diabetic patients were further treated with either multifactorial intervention (group A), or intensive insulin therapy (group B) for 2 weeks </plain></SENT>
<SENT sid="4" pm="."><plain>Both FMD and vWF measurement were repeated at the same time </plain></SENT>
<SENT sid="5" pm="."><plain>FMD was reassessed 90 days after intervention.ResultsCompared with healthy subjects, FMD in diabetic patients was significantly lower (group A: 15.99 ± 7.81 % vs. 25.17 ± 7.12 %, P &lt; 0.01; group B: 16.85 ± 7.30 % vs. 25.17 ± 7.12%, P &lt; 0.01), plasma vWF was significantly higher (group A: 224.34 ± 7.36 U/l vs. 109.69 ± 6.30 U/l, P &lt; 0.01; group B: 219.18 ± 6.92 U/l vs. 109.69 ± 6.30 U/l, P &lt; 0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>After treatment, there was no significant change of FMD in either group </plain></SENT>
<SENT sid="7" pm="."><plain>The vWF did not change after multifactorial intervention (220.96 ± 6.85 U/l vs. 224.34 ± 7.36 U/l, P = 0.49), but significantly decreased after intensive insulin therapy (155.08 ± 11.82 U/l vs. 219.18 ± 6.92 U/l, P = 0.0013).ConclusionsIntensive insulin therapy significantly improves endothelial injury/dysfunction as measured by vWF in early stage type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>Further study is needed to determine whether plasma vWF can help early identification, stratification and management of diabetic <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e>.American Journal of <z:hpo ids='HP_0000822'>Hypertension</z:hpo> 2012; doi:10.1038/ajh.2012.122 </plain></SENT>
</text></document>